Development and validation of the gastroesophageal reflux disease treatment satisfaction questionnaire

Digestive Diseases and Sciences

Volumn 50, Issue 11, 2005, Pages 2025-2033

  Shikiar, Richard ^a   Flood, Emuella ^a   Siddique, Reshmi ^b   Howell, Jamie ^b,c   Dodd, Sheri L ^b  

^a MEDTAP International Inc   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c Ortho Biotech Products LP   (United States)

Author keywords

GERD; H 2 receptor antagonists; Patient satisfaction; Proton pump inhibitors; Questionnaire; Validation

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ARTICLE; GASTROESOPHAGEAL REFLUX; HUMAN; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGED; ANTI-ULCER AGENTS; BENZIMIDAZOLES; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PATIENT SATISFACTION; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 27144501469     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-3002-1     Document Type: Article

References (16)

1. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd: Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112:1448-1456, 1997
2. Farup C, Kleinman L, Sloan S, et al.: The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med 161:45-52, 2001
3. Vigneri S, Termini R, Leandro G, et al.: A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 333:1106-1110, 1995
4. Rothman M, Farup C, Stewart W, Helbers L, Zeldis J: Symptoms associated with gastroesophageal reflux disease: Development of a questionnaire for use in clinical trials. Dig Dis Sci 46:1540-1549, 2001
5. Shikiar R, Rentz AM: Satisfaction with medication: an overview of conceptual, methodological, and regulatory issues. Value in Health 7:204-215, 2004
6. Shikiar R, Rentz AM, Barone J, Duncanson F, Katz E: Patient satisfaction with ofloxacin (F) and polymyxin B/Neomycin/Hydrocortisone in the treatment of otitis externa: results from two randomized clinical trials. Journal of Managed Care Medicine 6:24-27, 2002
7. Thompson JW, Bost J, Ahmed F, Ingalls CE, Sennett C: The NCQA's quality compass: evaluating managed care in the United States. Health Aff (Millwood) 17:152-158, 1998
8. Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M: Issues in the measurement of satisfaction with treatment. Am J Manag Care 3:579-594, 1997
9. Atkinson MJ, Sinha A, Hass SL, et al.: Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication, using a national panel study of chronic disease. Health and Qual Life Outcomes 2:12, 2004
10. Damiano A, Siddique R, Xiao X, Johanson J, Sloan S: Reductions in symptom distress reported by patients with moderately severe, nonerosive gastroesophageal reflux disease treated with rabeprazole. Dig Dis Sci 2003:657-662, 2003
11. Cronbach L: Coefficient alpha and the internal structure of tests. Psychometrika 16:297-334, 1951
12. Nunnally JC, Bernstein IH: Psychometric Theory, 3rd ed. New York, McGraw-Hill, 1994
13. Cohen J: Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ, Lawrence Erlbaum Associates, 1988
14. Atkinson MJ, Sinha A, Hass SL, et al.: Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health and Quality of Life Outcomes 2:1-13, 2004
15. Revicki DA: Patient assessment of treatment satisfaction: methods and practical issues. Gut 53(Suppl 4):iv4-44, 2004
16. Coyne KS, Wiklund I, Schmier J, Hailing K, Degl' Innocenti A, Revicki D. Development and validation of a disease-specific treatment satisfaction questionnaire for gastroesophageal reflux disease. Aliment Pharmacol Ther 18:907-915, 2003